GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Wright Medical Group Inc (FRA:WM3) » Definitions » Days Sales Outstanding

Wright Medical Group (FRA:WM3) Days Sales Outstanding : 60.05 (As of Jun. 2015)


View and export this data going back to . Start your Free Trial

What is Wright Medical Group Days Sales Outstanding?

Wright Medical Group's average Accounts Receivable for the three months ended in Jun. 2015 was €47.2 Mil. Wright Medical Group's Revenue for the three months ended in Jun. 2015 was €71.7 Mil. Hence, Wright Medical Group's Days Sales Outstanding for the three months ended in Jun. 2015 was 60.05.

The historical rank and industry rank for Wright Medical Group's Days Sales Outstanding or its related term are showing as below:

FRA:WM3' s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.19   Med: 72.34   Max: 80.01
Current: 62.39

During the past 13 years, Wright Medical Group's highest Days Sales Outstanding was 80.01. The lowest was 53.19. And the median was 72.34.

FRA:WM3's Days Sales Outstanding is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 64.2 vs FRA:WM3: 62.39

Wright Medical Group's Days Sales Outstanding declined from Jun. 2014 (66.06) to Jun. 2015 (60.05).


Wright Medical Group Days Sales Outstanding Historical Data

The historical data trend for Wright Medical Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wright Medical Group Days Sales Outstanding Chart

Wright Medical Group Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.50 72.50 110.76 59.03 60.27

Wright Medical Group Quarterly Data
Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.06 69.60 61.05 60.28 60.05

Competitive Comparison of Wright Medical Group's Days Sales Outstanding

For the Medical Devices subindustry, Wright Medical Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wright Medical Group's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Wright Medical Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Wright Medical Group's Days Sales Outstanding falls into.



Wright Medical Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Wright Medical Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2014 is calculated as

Days Sales Outstanding (A: Dec. 2014 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2013 ) + Accounts Receivable (A: Dec. 2014 )) / count ) / Revenue (A: Dec. 2014 )*Days in Period
=( (33.446 + 46.381) / 2 ) / 241.7*365
=39.9135 / 241.7*365
=60.27

Wright Medical Group's Days Sales Outstanding for the quarter that ended in Jun. 2015 is calculated as:

Days Sales Outstanding (Q: Jun. 2015 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2015 ) + Accounts Receivable (A: Jun. 2015 )) / count ) / Revenue (A: Jun. 2015 )*Days in Period
=( (48.753 + 45.561) / 2 ) / 71.654*365 / 4
=47.157 / 71.654*365 / 4
=60.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wright Medical Group  (FRA:WM3) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Wright Medical Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Wright Medical Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Wright Medical Group (FRA:WM3) Business Description

Traded in Other Exchanges
N/A
Address
Wright Medical Group Inc, through Wright Medical Technology, Inc. and other operating subsidiaries, is a specialty orthopaedic company, that provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients' lifestyles. The Company provides surgical solutions for the foot and ankle market and markets its products in over 60 countries. Its business includes products that are used in foot and ankle repair, upper extremity products, and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and their patients. Extremity hardware includes implants and other devices to replace or reconstruct injured or diseased joints and bones of the foot, ankle, hand, wrist, fingers, toes, elbow and shoulder, which it generally refer to as either foot and ankle or upper extremity products. The Company's manufacturing and warehousing operations are located in Arlington, Tennessee. Outside the U.S., The Company has distribution and administrative facilities in Amsterdam, the Netherlands, and sales and distribution offices in Canada, Australia, and Europe. The Company operates its continuing operations as one reportable segment and offer products in extremity reconstruction and biologics. The Company's products include CHARLOTTE, CLAW II, DARCO, EVOLVE, MICRONAIL, GRAFTJACKET, OSTEOSET. Its competitors include major companies in the orthopaedic and biologics industries, as well as academic institutions and other public and private research organizations that continue to conduct research, seek patent protection and establish arrangements for commercializing products. The Company's products are strictly regulated by the FDA under the Food, Drug, and Cosmetic Act. Some of its products are also regulated by state agencies.

Wright Medical Group (FRA:WM3) Headlines

No Headlines